Age‑Specific HPV Prevalence and Cervical Cancer Screening Utilisation in Ethiopia: A Systematic Review of Epidemiologic Need Versus Service Uptake

Cervical cancer remains a major public health challenge in Ethiopia. High-risk HPV types 16 and 18 account for approximately 70% of cervical cancer cases globally, yet screening uptake in the country remains critically low. Recent evidence indicates that cervical cancer screening utilisation among Ethiopian female healthcare workers is only about 13.6%, while national screening practice among women is estimated at roughly 14%. These figures highlight a substantial gap in prevention and early detection efforts. I am inviting collaborators based in Ethiopia who have an interest in cervical cancer prevention, HPV, or women’s health research to join a collaborative research initiative. Contributors will have the opportunity to participate in key stages of the project, including literature review, data collection, study screening, data extraction, analysis, and manuscript preparation. The collaboration aims to generate high-quality evidence that can inform policy, improve screening strategies, and strengthen cervical cancer prevention efforts in Ethiopia. Researchers, clinicians, public health professionals, and graduate students with relevant expertise are encouraged to express their interest.